| __timestamp | ACADIA Pharmaceuticals Inc. | Amicus Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 47624000 |
| Thursday, January 1, 2015 | 73869000 | 76943000 |
| Friday, January 1, 2016 | 99284000 | 104793000 |
| Sunday, January 1, 2017 | 149189000 | 149310000 |
| Monday, January 1, 2018 | 187163000 | 270902000 |
| Tuesday, January 1, 2019 | 240385000 | 286378000 |
| Wednesday, January 1, 2020 | 319130000 | 308443000 |
| Friday, January 1, 2021 | 239415000 | 272049000 |
| Saturday, January 1, 2022 | 361575000 | 276677000 |
| Sunday, January 1, 2023 | 351619000 | 152381000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, ACADIA Pharmaceuticals Inc. and Amicus Therapeutics, Inc. have demonstrated significant investment in R&D, reflecting their dedication to advancing medical science.
From 2014 to 2023, ACADIA Pharmaceuticals Inc. increased its R&D spending by nearly 480%, peaking in 2022 with a 361% rise from its 2014 levels. Meanwhile, Amicus Therapeutics, Inc. saw a 320% increase over the same period, with its highest expenditure in 2020.
While both companies have shown impressive growth, ACADIA's R&D spending surpassed Amicus in recent years, particularly in 2022, when it outspent Amicus by 31%. This trend highlights ACADIA's aggressive push towards innovation, setting the stage for future breakthroughs.
Research and Development: Comparing Key Metrics for Eli Lilly and Company and Amicus Therapeutics, Inc.
R&D Spending Showdown: Novo Nordisk A/S vs Amicus Therapeutics, Inc.
R&D Spending Showdown: Novartis AG vs ACADIA Pharmaceuticals Inc.
Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Amicus Therapeutics, Inc.
R&D Insights: How Exelixis, Inc. and Amicus Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Amicus Therapeutics, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
R&D Spending Showdown: Perrigo Company plc vs Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Amicus Therapeutics, Inc. vs Geron Corporation
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Galapagos NV